Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hercend

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
European Journal of Immunology|April 1, 1991
Studies on the human T cell receptor alpha/beta variable region genes. I. Identification of 7 additional V alpha subfamilies and 14 J alpha gene segmentsS Roman-Roman, L Ferradini, J Azocar, et al.
Annual Review of Immunology|January 1, 1984
The human T-cell receptorS C Meuer, O Acuto, T Hercend, et al.
European Journal of Immunology|April 1, 1991
Studies on the human T cell receptor alpha/beta variable region genes. II. Identification of four additional V beta subfamiliesL Ferradini, S Roman-Roman, J Azocar, et al.
Molecular Immunology|April 1, 1993
Alternatively spliced T cell receptor transcripts expressed in human T lymphocytesS Roman-Roman, L Ferradini, O Azogui, et al.
Leukemia|May 1, 1992
In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorderC Bayle, I Vitté-Mony, P Lang, et al.
Cancer Research|August 1, 1993
Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanomaA Mackensen, L Ferradini, G Carcelain, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2B Escudier, F Farace, E Angevin, et al.
Cancer Research|January 15, 1996
T-cell receptor repertoire in neuroblastoma patientsD Valteau, V Scott, G Carcelain, et al.
The Journal of Experimental Medicine|October 1, 1990
T cell target 1 (TCT.1): a novel target molecule for human non-major histocompatibility complex-restricted T lymphocytesF Mami-Chouaib, C Miossec, P Del Porto, et al.
The Journal of Clinical Investigation|March 1, 1993
Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansionL Ferradini, A Mackensen, C Genevée, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
European Journal of Immunology|April 1, 1991
Studies on the human T cell receptor alpha/beta variable region genes. I. Identification of 7 additional V alpha subfamilies and 14 J alpha gene segmentsS Roman-Roman, L Ferradini, J Azocar, et al.
Annual Review of Immunology|January 1, 1984
The human T-cell receptorS C Meuer, O Acuto, T Hercend, et al.
European Journal of Immunology|April 1, 1991
Studies on the human T cell receptor alpha/beta variable region genes. II. Identification of four additional V beta subfamiliesL Ferradini, S Roman-Roman, J Azocar, et al.
Molecular Immunology|April 1, 1993
Alternatively spliced T cell receptor transcripts expressed in human T lymphocytesS Roman-Roman, L Ferradini, O Azogui, et al.
Leukemia|May 1, 1992
In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorderC Bayle, I Vitté-Mony, P Lang, et al.
Cancer Research|August 1, 1993
Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanomaA Mackensen, L Ferradini, G Carcelain, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2B Escudier, F Farace, E Angevin, et al.
Cancer Research|January 15, 1996
T-cell receptor repertoire in neuroblastoma patientsD Valteau, V Scott, G Carcelain, et al.
The Journal of Experimental Medicine|October 1, 1990
T cell target 1 (TCT.1): a novel target molecule for human non-major histocompatibility complex-restricted T lymphocytesF Mami-Chouaib, C Miossec, P Del Porto, et al.
The Journal of Clinical Investigation|March 1, 1993
Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansionL Ferradini, A Mackensen, C Genevée, et al.
Pageof 13